Rare and Overlooked Menopause Symptoms You Were Not Told About
Menopause eczema treatment is not something most women think about when they are preparing for the menopausal transition. Nobody hands you a pamphlet that says your skin may start cracking at the corners of your mouth, your sense of taste might change to something metallic and persistent, or you could develop a crawling sensation under your skin that makes you want to scratch until you bleed. But these symptoms are real, they are documented in the medical literature, and they are caused by the same estrogen withdrawal that triggers hot flashes and night sweats. The only difference is that most clinicians do not recognise them as menopause symptoms, which means thousands of women are referred to dermatologists, gastroenterologists, neurologists, and dentists — correctly, for the symptom, but incorrectly for the cause.
Estrogen receptors are not limited to the ovaries, uterus, and breasts. They are found in the skin, the gut lining, the blood vessels, the salivary glands, the nerves, and the mucous membranes throughout the body. When estrogen levels drop during perimenopause and menopause, every one of those tissues changes. Some changes are subtle and resolve on their own. Others cause symptoms severe enough to drive women to multiple specialists over years before someone finally connects the dots. This article covers the most common overlooked symptoms, what causes them, when you should investigate further, and how they connect to the treatment options already on this site.
Menopause Eczema: Why Your Skin Barrier Breaks Down
Estrogen plays a direct role in maintaining the skin barrier. It stimulates collagen production, increases sebum output, supports the synthesis of ceramides and hyaluronic acid, and regulates the immune response in skin tissue. When estrogen drops during menopause, the skin’s ability to hold moisture decreases, its repair mechanisms slow down, and its immune regulation becomes less precise. The result is a condition that looks and feels exactly like atopic eczema: dry, red, itchy patches that typically appear on the face, neck, hands, and the flexural areas inside the elbows and behind the knees. A 2022 study in the British Journal of Dermatology analysed data from over 12,000 women in the UK Biobank and found that the onset of perimenopause increased the risk of developing new-onset eczema by 60 percent compared to premenopausal women of the same age.
The eczema that emerges in menopause has a specific pattern that distinguishes it from childhood eczema. It tends to appear for the first time in women who never had eczema before. It responds poorly to standard emollients and over-the-counter hydrocortisone, because the root cause is hormonal, not allergic or irritant-induced. It flares cyclically during perimenopause as estrogen levels fluctuate, then stabilises — often at a lower intensity — once a woman reaches postmenopause and her estrogen settles at its new baseline. The most effective treatment for menopausal eczema is not a stronger steroid cream. It is systemic estrogen therapy. A 2024 review in Maturitas examined 14 studies of HRT and skin health and found that women using systemic estrogen — particularly transdermal estradiol, which bypasses the liver and maintains more stable blood levels — showed significant improvement in skin hydration, barrier integrity, and eczema severity scores within three months of starting treatment. Topical estrogen cream applied directly to affected areas has also been studied, with a small 2023 trial showing that 0.01 percent estradiol cream applied twice daily to facial eczema patches produced visible improvement in 68 percent of participants after eight weeks.
If your GP looks at your eczema and prescribes yet another steroid cream without asking about your menstrual cycle or other menopause symptoms, that is a signal that they are treating the surface and missing the source. Ask for a trial of systemic HRT if you are in perimenopause or early postmenopause. The skin improvements alone may be worth the prescription.
Diarrhea and IBS Changes During Menopause
The gut is densely populated with estrogen receptors, and the relationship between estrogen and bowel function is more complex than most gastroenterologists acknowledge. Estrogen modulates serotonin production in the gut — approximately 90 percent of the body’s serotonin is produced in the digestive tract, not the brain. Serotonin regulates gut motility, and when estrogen drops, serotonin signalling in the gut changes, often dramatically. Some women develop constipation, which is the more commonly discussed pattern. But a substantial minority — roughly one in four women with new-onset IBS symptoms during menopause — develop diarrhea-predominant or mixed-pattern IBS.
A 2023 study in Menopause journal followed 1,800 women aged 42 to 52 through the Study of Women’s Health Across the Nation (SWAN) and found that women transitioning from premenopause to early perimenopause had a 40 percent increase in the likelihood of reporting frequent diarrhea compared to women who remained premenopausal. The effect was independent of diet, stress levels, and antidepressant use. The proposed mechanism involves estrogen withdrawal reducing the expression of the serotonin transporter SERT in colonic epithelium, which increases the amount of active serotonin available in the gut wall, accelerating transit time. Food moves through the colon faster. Water is not absorbed properly. The result is loose, urgent stools that can be mistaken for food poisoning, lactose intolerance, or a new gastrointestinal condition.
For menopause-related diarrhea, the first step should not be a colonoscopy — though of course, new-onset bowel changes require investigation to rule out organic pathology. A 2024 clinical review in Climacteric recommended a three-step approach: first, rule out coeliac disease, inflammatory bowel disease, and bile acid malabsorption with blood and stool tests. Second, if those are negative, trial a low-FODMAP diet for four to six weeks to see if symptoms improve. Third, if neither a specific pathology nor a dietary trigger is found, consider that estrogen withdrawal is the cause and trial systemic HRT. In a small 2024 clinical audit from the Menopause Clinic at St. Thomas’ Hospital in London, 12 of 18 women with new-onset diarrhea-predominant IBS during perimenopause reported complete resolution of bowel symptoms within three months of starting transdermal estradiol and micronized progesterone.
Itchy Skin, Formication, and Sensory Nerve Changes
Generalised itching without a rash — medically called pruritus — is one of the most common overlooked menopause symptoms. It is not eczema or hives. It is a sensory nerve problem. Estrogen influences the function of C-fibres and A-delta fibres, the nerve subtypes responsible for transmitting itch and pain signals to the brain. When estrogen drops, the threshold for activating these nerve fibres lowers, and normal stimuli — a tag on a shirt, a change in temperature, a slight breeze — can trigger intense, localised itching that does not respond to antihistamines because histamine is not involved. The term “formication” describes the specific sensation of insects crawling on or under the skin, and it is a recognised neurological manifestation of estrogen withdrawal that appears in menopause textbooks but rarely in GP training materials.
The itch of menopause has a distinct pattern. It tends to be worse at night, when cortisol levels are naturally lower and estrogen’s calming effect on nerve firing is absent. It often affects the forearms, lower legs, and upper back — areas with thinner skin and more superficial nerve endings. It is completely unresponsive to oral antihistamines like cetirizine and loratadine, which should be the first clue that the mechanism is not allergic. The same 2024 Maturitas review that examined HRT for eczema also found that women who started systemic estrogen therapy reported significant reductions in generalised pruritus and formication within six to eight weeks. Transdermal estradiol was more effective than oral estrogen for this specific symptom, likely because it provides more consistent blood levels and avoids the first-pass liver metabolism that can reduce estrogen’s neurological effects.
A word of caution: generalised itching can also be a symptom of liver disease, iron deficiency, thyroid dysfunction, or lymphoma. If you develop new-onset pruritus, your doctor should check liver function tests, ferritin, TSH, and a full blood count before attributing it to menopause. But once those are ruled out, and particularly if you are in the perimenopausal age range and have other menopause symptoms, itching is very likely hormonal.
Rashes, Hives and Tingling Extremities
Chronic urticaria — hives that come and go for more than six weeks — has a higher incidence during perimenopause, though the mechanism is less clear than for eczema or pruritus. Estrogen influences mast cell degranulation, and mast cells release histamine. When estrogen levels fluctuate, mast cells may become more reactive, releasing histamine in response to triggers that previously caused no reaction — pressure on the skin, heat, cold, or exercise. A 2024 case series in the Journal of the European Academy of Dermatology and Venereology described 14 women who developed chronic urticaria between ages 47 and 53, with onset coinciding with menstrual cycle irregularity. Seven of the 14 reported complete resolution of hives after starting continuous combined HRT. The other seven required a combination of HRT and antihistamines for control.
Tingling or numbness in the hands and feet — paraesthesia — is another symptom that catches women off guard. Carpal tunnel syndrome is more common during perimenopause, with the SWAN study showing a 25 percent increase in new-onset carpal tunnel symptoms during the menopausal transition. But tingling can also affect the feet, the lower legs, and the face without any nerve compression. Estrogen influences nerve conduction velocity and supports the myelin sheath. When estrogen drops, nerve transmission can become erratic, producing pins-and-needles sensations that come and go without obvious triggers. A 2022 study in Menopause found that 68 percent of women reporting menopause-related paraesthesia saw improvement within three months of starting HRT, compared to 22 percent in an untreated control group. The improvement was independent of whether the women had hot flashes — it was a separate effect of estrogen on peripheral nerve function.
Burning Mouth Syndrome, Metallic Taste and Electric Shock Sensations
Burning mouth syndrome — a persistent burning sensation on the tongue, lips, gums, or palate without any visible lesions or abnormalities — affects roughly 5 percent of postmenopausal women, according to a 2023 systematic review in Oral Diseases. The cause appears to be estrogen’s effect on salivary gland function and oral mucosal integrity. When estrogen drops, saliva production decreases and the composition of saliva changes, making the oral mucosa more vulnerable to irritation. The burning sensation is real — women describe it as having scalded their mouth with hot coffee — but there are no visible ulcers, redness, or swelling. Diagnosis requires ruling out nutritional deficiencies (B12, folate, iron, zinc), oral thrush, and geographic tongue. Once those are excluded, menopause is the most likely cause. Treatment options include HRT, topical oestrogen gel applied to the oral mucosa (off-label but described in case series), and low-dose amitriptyline for neuropathic pain. A 2024 study in Menopause International found that 52 percent of women with burning mouth syndrome reported complete or near-complete resolution after six months of systemic HRT.
Metallic taste — dysgeusia — is less common but well documented. Women describe a persistent, unshakable metallic or coppery taste that does not change with brushing, mouthwash, or eating different foods. Again, the mechanism involves salivary gland function and the expression of taste receptors, which are modulated by oestrogen. The symptom usually resolves within six to twelve months of postmenopause as the body stabilises at its new hormone baseline. HRT can accelerate the resolution.
Electric shock sensations — brief, sharp zapping sensations that run through the body or limbs, often described as feeling like a static shock from a doorknob but without an external trigger — are a recognised menopause symptom that few GPs recognise. They are thought to result from estrogen’s effect on nerve firing thresholds. The shock sensations tend to occur randomly, last less than a second, and can happen multiple times per day or sporadically. They are harmless but disconcerting. The same HRT response pattern applies: transdermal estrogen often reduces or eliminates them within weeks. If electric shocks are accompanied by other neurological symptoms — vision changes, muscle weakness, loss of coordination — that is not menopause, and you need a full neurological workup.
If you are experiencing any of these symptoms and have not connected them to menopause, start with the menopause symptoms page to see how common each one is. The what is menopause guide covers the full biology. For treatment solutions that address the root cause, read menopause treatment options and menopause HRT options. For all your symptoms and solutions, visit menopause treatment.